Hemorrhagic stroke - complications

Hemorrhagic stroke complications range from immediate threats like rebleeding, vasospasm, and increased ICP, to later problems such as hydrocephalus, seizures, and infections. Long-term complications include cognitive and emotional deficits which all contribute to the morbidity and mortality associated with hemorrhagic stroke, necessitating comprehensive management and rehabilitation strategies.

Rebleeding: Following a hemorrhagic stroke, particularly subarachnoid hemorrhage (SAH), rebleeding is a significant and potentially fatal complication. It typically occurs within the first 24 hours but remains a risk for several weeks. The underlying cause is often the rupture of an unsecured aneurysm. Rebleeding leads to a sudden increase in intracranial pressure (ICP), further brain damage, and a worsened prognosis. Symptoms mirror the initial hemorrhage but can be more severe. Management involves immediate blood pressure control, antifibrinolytic agents (e.g., tranexamic acid) to prevent clot lysis, and definitive treatment of the aneurysm (surgical clipping or endovascular coiling). A common misconception is that once the initial bleed stops, the risk is over. However, meticulous monitoring and timely intervention are crucial to prevent rebleeding and improve patient outcomes. Rebleeding is a leading cause of mortality in SAH patients.

Vasospasm: Vasospasm, a narrowing of the cerebral arteries, is a delayed complication primarily associated with subarachnoid hemorrhage (SAH). It typically develops 3-14 days after the initial bleed, peaking around day 7. The spasm reduces blood flow to the brain, leading to secondary ischemic injury and neurological deficits. The precise mechanism is not fully understood but involves the release of vasoactive substances from the blood in the subarachnoid space. Diagnosis is confirmed by transcranial Doppler (TCD) ultrasound or angiography. Treatment includes nimodipine (a calcium channel blocker), which prevents arterial constriction, and maintaining euvolemia and hypertension (induced hypertension) to improve cerebral perfusion. A key historical point is the understanding of vasospasm significantly improved with the advent of TCD. Without proper management, vasospasm can result in permanent brain damage or death.

Hydrocephalus: Hydrocephalus, an abnormal accumulation of cerebrospinal fluid (CSF) in the brain's ventricles, is a common complication of hemorrhagic stroke, especially SAH and intraventricular hemorrhage (IVH). The hemorrhage can obstruct the flow of CSF, either within the ventricles (obstructive hydrocephalus) or at the arachnoid granulations (communicating hydrocephalus), which are responsible for CSF absorption. Hydrocephalus increases ICP, leading to neurological deterioration. Symptoms include headache, nausea, vomiting, lethargy, and altered mental status. Diagnosis is made via CT or MRI scans. Treatment options include external ventricular drainage (EVD), a temporary measure to drain CSF and reduce ICP, or a permanent shunt (ventriculoperitoneal shunt) to divert CSF to another part of the body. Misconception: hydrocephalus is always a rapid and obvious deterioration; sometimes it is subtle and requires close monitoring.

Seizures: Seizures are a relatively common complication following hemorrhagic stroke, occurring in both the acute and chronic phases. The presence of blood in the brain tissue irritates the neurons and disrupts normal electrical activity, leading to seizures. Seizures can be generalized (affecting the entire brain) or focal (localized to a specific area). Status epilepticus, a prolonged or repetitive seizure lasting more than 5 minutes, is a medical emergency. Management involves anticonvulsant medications (e.g., phenytoin, levetiracetam) to control seizure activity. Prophylactic anticonvulsants are sometimes considered in patients with a high risk of seizures, but their routine use is controversial due to potential side effects. Recurrent seizures can worsen brain damage and impair neurological recovery. The occurrence of seizures increases morbidity and mortality after hemorrhagic stroke.

Increased Intracranial Pressure (ICP): Hemorrhagic stroke, by its nature, often causes a rapid increase in intracranial pressure (ICP). The presence of blood within the skull, whether it's in the brain tissue, ventricles, or subarachnoid space, takes up space and compresses the brain. Elevated ICP reduces cerebral blood flow, leading to ischemia and further brain damage. Signs and symptoms include headache, vomiting, altered level of consciousness, pupillary changes, and Cushing's triad (hypertension, bradycardia, and irregular respirations). Management focuses on reducing ICP through various strategies: elevating the head of the bed, administering osmotic diuretics (e.g., mannitol, hypertonic saline), controlled hyperventilation, and, in severe cases, surgical decompression (craniectomy). ICP monitoring is essential to guide treatment. Untreated, elevated ICP can lead to herniation and death. A key fact: normal ICP is between 5-15 mmHg.

Hyponatremia: Hyponatremia, a low sodium level in the blood, is a frequent electrolyte imbalance observed after hemorrhagic stroke, particularly SAH. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) and cerebral salt wasting (CSW) are the main causes. SIADH results in excessive ADH release, leading to water retention and dilutional hyponatremia. CSW, on the other hand, involves renal salt wasting and subsequent water loss, resulting in hypovolemic hyponatremia. Symptoms of hyponatremia include headache, nausea, vomiting, confusion, and seizures. Treatment depends on the underlying cause. SIADH is managed with fluid restriction and, in some cases, vasopressin receptor antagonists. CSW requires sodium replacement and, in some cases, mineralocorticoids. Monitoring sodium levels is crucial to prevent neurological complications associated with hyponatremia.

Aspiration Pneumonia: Aspiration pneumonia is a common complication after stroke, including hemorrhagic stroke, particularly in patients with impaired swallowing (dysphagia). Dysphagia can result from damage to the brainstem or cortical areas involved in swallowing control. Aspiration occurs when food, fluids, or saliva enter the lungs, leading to inflammation and infection. Symptoms include cough, fever, shortness of breath, and chest pain. Diagnosis is made via chest X-ray. Management involves antibiotics to treat the infection, supportive care (oxygen therapy), and measures to prevent further aspiration, such as thickened liquids, modified diets, and feeding tubes. Aspiration precautions are essential in all stroke patients with dysphagia. A speech-language pathologist plays a crucial role in evaluating and managing swallowing difficulties.

Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE): Patients with hemorrhagic stroke are at increased risk of developing deep vein thrombosis (DVT) and pulmonary embolism (PE) due to immobility and hypercoagulability. DVT is the formation of a blood clot in a deep vein, typically in the legs. PE occurs when a DVT travels to the lungs and blocks a pulmonary artery. Symptoms of DVT include leg pain, swelling, and redness. Symptoms of PE include sudden shortness of breath, chest pain, and cough. Prevention involves early mobilization, compression stockings, and, in some cases, prophylactic anticoagulation (if the risk of bleeding is outweighed by the risk of thromboembolism). Diagnosis is made via Doppler ultrasound (for DVT) and CT angiography (for PE). Treatment involves anticoagulants (e.g., heparin, warfarin, direct oral anticoagulants). PE can be life-threatening and requires prompt diagnosis and treatment.

Cardiac Complications: Hemorrhagic stroke can lead to various cardiac complications, including arrhythmias (e.g., atrial fibrillation), myocardial infarction (heart attack), and stress-induced cardiomyopathy (Takotsubo cardiomyopathy). These complications can arise due to the systemic stress response triggered by the stroke, as well as direct effects on the autonomic nervous system. Cardiac arrhythmias can increase the risk of thromboembolic events and worsen neurological outcomes. Stress cardiomyopathy, characterized by temporary weakening of the heart muscle, can lead to heart failure. Monitoring cardiac function is essential in stroke patients, and treatment is tailored to the specific cardiac complication. A baseline ECG is recommended. Management involves addressing the underlying cause and providing supportive care.

Cognitive and Emotional Sequelae: Beyond the immediate physical complications, hemorrhagic stroke often results in long-term cognitive and emotional deficits. Cognitive impairments can include problems with memory, attention, executive function, and language. Emotional sequelae can include depression, anxiety, and mood swings. These deficits can significantly impact a patient's quality of life and ability to function independently. Rehabilitation plays a crucial role in addressing these issues. Cognitive rehabilitation therapy can help improve cognitive function, and psychotherapy or medication can treat emotional disorders. Social support is also essential for patients and their families to cope with the challenges of stroke recovery. A common misconception is that cognitive deficits will automatically improve after the acute phase; rehabilitation is crucial.

Browse public study notes